Clinical trial
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular…
NCT00359801 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00359801 |
|---|---|
| Title | Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety |
| Official title | An International, Multicenter, Large Simple Trial To Evaluate The Long-Term Pulmonary And Cardiovascular Safety Of Exubera In Patients With Diabetes Mellitus |
| Acronym | VOLUME |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care |
| Enrollment | 1,976 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Aug 2, 2006 |
| Last update posted | Feb 2, 2010 |
| Countries | Germany, Puerto Rico, Sweden, United Kingdom, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: